… Some limitations inherent to the main EASTBOURNE prospective registry may also apply
to the present analysis. First, it was a single-arm open-label registry and the decision to use …

… sirolimus-coated balloons (SCB) are being investigated for several coronary artery disease
… Figure 3 describes the clinical outcome in the diabetic population vs the nondiabetic one. …

… The EASTBOURNE registry (NCT03085823) is a prospective… registry aiming to enroll a
real-world, all-comer population of … percentages of diabetes (34%) and acute coronary syndrome (…

… population and other groups with a higher than expected clinical outcome rate such as
diabetics and patients … balloon angioplasty in a large-scale, prospective registry study. J Am Coll …

… in coronary artery disease [[8], [9], [10], [11]]. Given the absence of any direct comparison
between sirolimus and paclitaxel in an “all comer” population… of the EASTBOURNE registry: the …

… in an all-comer registry of the first consecutive patients with … prospective, multicenter
EASTBOURNE registry, that will enroll around 1000 patients with any type of coronary artery disease…

… , all-comer population of coronary artery disease patients and is the largest prospective study
… We here report a prespecified analysis of the prospective EASTBOURNE registry aiming to …

… “Clinical performance of a novel sirolimus-coated balloon in coronary artery disease:
EASTBOURNE registry.” by Cortese et al. … EASTBOURNE was an international …

… all the procedures included in the EASTBOURNE Registry (… The EASTBOURNE (All-Comers
Sirolimus-Coated Balloon … included, enrolling real-world coronary artery disease patients. …

… of the patients (Table 1) showed 45% of diabetics and 48% … safety in an all comer small
populations of 32 patients; the … the ongoing investigator-driven EASTBOURNE registry, which will …